Crowell & Moring Advises Cure Ventures in Series A Financing of Tortugas Neuroscience
Firm News | less than 1 min read | 04.21.26
Boston – April 21, 2026: Crowell & Moring advised founding investor Cure Ventures in the Series A financing of Tortugas Neuroscience, a neurology-focused biotech company.
Cure Ventures co-led the Series A round in partnership with The Column Group and AN Venture Partners. Proceeds from the financing will support Tortugas’ ongoing research and development initiatives regarding new and major neurology and neuropsychiatric disorders, including the completion of Phase 2 clinical trials for its two lead candidates.
The financing transaction was led by partner Kurt Machemer (Boston).
Read more here.
Insights
Firm News | 1 min read | 06.22.26
Crowell & Moring Names Andrea Markstrom as Chief Information Officer
Crowell & Moring has named Andrea Markstrom as Chief Information Officer to lead the firm’s global technology platform and operations teams and drive technology strategy that will advance the objectives of the firm and its clients.
Firm News | 1 min read | 06.16.26
World Trademark Review Recognizes Four Crowell Attorneys in the 2026 Global Leaders Guide
Firm News | 2 min read | 06.11.26
Crowell & Moring Honored with Outstanding Achievement Award by the Washington Lawyers' Committee
Firm News | 1 min read | 06.11.26
Crowell & Moring Partner Emma Wright Appointed to UK Government's Digital ID Advisory Group
